5 completed. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Paliperidone: new trials by email Literature Review of Paliperidone trials Research Report on Paliperidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Substance Misuse To Psychosis for Stimulants Aripiprazole, Paliperidone, Treatment as Usual - Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders | Phase 2 / Phase 3 | Completed | The University of Hong Kong | 165 | 2019-06-01 | 2026-03-27 |
| A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication ASP4345, placebo, risperidone - Schizophrenia | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 233 | 2018-07-13 | 2024-11-12 |
| A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment Paliperidone - Schizophrenia | Phase 1 / Phase 2 | Completed | Pharmathen S.A. | 70 | 2018-03-11 | 2019-07-19 |
| Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder Paliperidone, Placebo - Obsessive-Compulsive Disorder | Phase 2 | Completed | University of South Florida | 34 | 2007-10-01 | 2014-02-06 |
| An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia paliperidone - Schizophrenia | Phase 2 | Completed | Janssen Pharmaceutical K.K. | 52 | 2005-02-01 | 2011-05-17 |
Schizophrenia (4) · Disease (1) · Obsessive-Compulsive Disorder (1) · Psychotic Disorders (1)
Astellas Pharma Global Development, Inc. (1) · Janssen Pharmaceutical K.K. (1) · Pharmathen S.A. (1) · The University of Hong Kong (1) · University of South Florida (1)
United States (2) · Hong Kong (1) · Jordan (1)
Eric A Storch, Ph.D. (1) · Lina Sabbah (1)